A citation-based method for searching scientific literature

Márcio Ribeiro, Tatiana R Rosenstock, Ana M Oliveira, Catarina R Oliveira, A Cristina Rego. Free Radic Biol Med 2014
Times Cited: 73







List of co-cited articles
785 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
Luana Naia, I Luísa Ferreira, Teresa Cunha-Oliveira, Ana I Duarte, Márcio Ribeiro, Tatiana R Rosenstock, Mário N Laço, Maria J Ribeiro, Catarina R Oliveira, Frédéric Saudou,[...]. Mol Neurobiol 2015
47
42

IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.
Carla Lopes, Márcio Ribeiro, Ana I Duarte, Sandrine Humbert, Frederic Saudou, Luís Pereira de Almeida, Michael Hayden, A Cristina Rego. Mol Neurobiol 2014
50
34

The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
Sandrine Humbert, Elzbieta A Bryson, Fabrice P Cordelières, Nathan C Connors, Sandeep R Datta, Steven Finkbeiner, Michael E Greenberg, Frédéric Saudou. Dev Cell 2002
354
20

Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
Luana Naia, Márcio Ribeiro, Joana Rodrigues, Ana I Duarte, Carla Lopes, Tatiana R Rosenstock, Michael R Hayden, A Cristina Rego. Neuropeptides 2016
25
56

IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
A I Duarte, G H Petit, S Ranganathan, J-Y Li, C R Oliveira, P Brundin, M Björkqvist, A C Rego. Exp Neurol 2011
25
36

Bioenergetic dysfunction in Huntington's disease human cybrids.
I Luisa Ferreira, Teresa Cunha-Oliveira, Maria V Nascimento, Márcio Ribeiro, M Teresa Proença, Cristina Januário, Catarina R Oliveira, A Cristina Rego. Exp Neurol 2011
37
24

Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
Márcio Ribeiro, Tatiana R Rosenstock, Teresa Cunha-Oliveira, Ildete L Ferreira, Catarina R Oliveira, A Cristina Rego. Free Radic Biol Med 2012
45
20

Mechanisms of neurodegeneration in Huntington's disease.
Joana M Gil, Ana Cristina Rego. Eur J Neurosci 2008
296
10

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
Patrick Weydt, Victor V Pineda, Anne E Torrence, Randell T Libby, Terrence F Satterfield, Eduardo R Lazarowski, Merle L Gilbert, Gregory J Morton, Theodor K Bammler, Andrew D Strand,[...]. Cell Metab 2006
433
10

Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
F Trettel, D Rigamonti, P Hilditch-Maguire, V C Wheeler, A H Sharp, F Persichetti, E Cattaneo, M E MacDonald. Hum Mol Genet 2000
468
9

Akt is altered in an animal model of Huntington's disease and in patients.
Emilie Colin, Etienne Régulier, Valérie Perrin, Alexandra Dürr, Alexis Brice, Patrick Aebischer, Nicole Déglon, Sandrine Humbert, Frédéric Saudou. Eur J Neurosci 2005
126
9

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?
Fares Bassil, Pierre-Olivier Fernagut, Erwan Bezard, Wassilios G Meissner. Prog Neurobiol 2014
127
9

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
736
9

Mitochondrial-dependent apoptosis in Huntington's disease human cybrids.
Ildete L Ferreira, Maria V Nascimento, Márcio Ribeiro, Sandra Almeida, Sandra M Cardoso, Manuela Grazina, João Pratas, Maria João Santos, Cristina Januário, Catarina R Oliveira,[...]. Exp Neurol 2010
44
15

FK506 ameliorates cell death features in Huntington's disease striatal cell models.
Tatiana R Rosenstock, Olga Martins de Brito, Vitoria Lombardi, Susana Louros, Marcio Ribeiro, Sandra Almeida, Ildete Luisa Ferreira, Catarina R Oliveira, A Cristina Rego. Neurochem Int 2011
22
27

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Li-Ying Han, Kalindi P Bakshi, Andres Stucky, Robert L Fuino, Krista R Kawaguchi, Andrew J Samoyedny, Robert S Wilson,[...]. J Clin Invest 2012
8

Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.
Diana Zala, Emilie Colin, Hélène Rangone, Géraldine Liot, Sandrine Humbert, Frédéric Saudou. Hum Mol Genet 2008
106
8

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
Alexander V Panov, Claire-Anne Gutekunst, Blair R Leavitt, Michael R Hayden, James R Burke, Warren J Strittmatter, J Timothy Greenamyre. Nat Neurosci 2002
734
8


The many faces of insulin-like peptide signalling in the brain.
Ana M Fernandez, Ignacio Torres-Alemán. Nat Rev Neurosci 2012
538
8

Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.
Ana C Silva, Sandra Almeida, Mário Laço, Ana I Duarte, Joana Domingues, Catarina R Oliveira, Cristina Januário, A Cristina Rego. Mitochondrion 2013
26
23

Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.
Luana Naia, Tatiana R Rosenstock, Ana M Oliveira, Sofia I Oliveira-Sousa, Gladys L Caldeira, Catarina Carmo, Mário N Laço, Michael R Hayden, Catarina R Oliveira, A Cristina Rego. Mol Neurobiol 2017
53
11

Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells.
Amy Lyons, Michael Coleman, Sarah Riis, Cedric Favre, Ciara H O'Flanagan, Alexander V Zhdanov, Dmitri B Papkovsky, Stephen D Hursting, Rosemary O'Connor. J Biol Chem 2017
53
11

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.
Liying Yang, Hongyan Wang, Lijun Liu, Anmu Xie. Front Neurosci 2018
60
10

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
Luana Naia, Teresa Cunha-Oliveira, Joana Rodrigues, Tatiana R Rosenstock, Ana Oliveira, Márcio Ribeiro, Catarina Carmo, Sofia I Oliveira-Sousa, Ana I Duarte, Michael R Hayden,[...]. J Neurosci 2017
29
20

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
914
6

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
775
6

Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Márcio Ribeiro, Ana C Silva, Joana Rodrigues, Luana Naia, A Cristina Rego. Toxicol Sci 2013
20
25




Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.
Aileen M Moloney, Rebecca J Griffin, Suzanne Timmons, Rosemary O'Connor, Rivka Ravid, Cora O'Neill. Neurobiol Aging 2010
483
6

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Eric Steen, Benjamin M Terry, Enrique J Rivera, Jennifer L Cannon, Thomas R Neely, Rose Tavares, X Julia Xu, Jack R Wands, Suzanne M de la Monte. J Alzheimers Dis 2005
6


Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
Jinho Kim, Jennifer P Moody, Christina K Edgerly, Olivia L Bordiuk, Kerry Cormier, Karen Smith, M Flint Beal, Robert J Ferrante. Hum Mol Genet 2010
204
6

Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors.
Jorge M A Oliveira, Sylvia Chen, Sandra Almeida, Rebeccah Riley, Jorge Gonçalves, Catarina R Oliveira, Michael R Hayden, David G Nicholls, Lisa M Ellerby, A Cristina Rego. J Neurosci 2006
100
6

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
562
6

Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
Ulziibat Shirendeb, Arubala P Reddy, Maria Manczak, Marcus J Calkins, Peizhong Mao, Danilo A Tagle, P Hemachandra Reddy. Hum Mol Genet 2011
246
6

Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.
Wenjun Song, Jin Chen, Alejandra Petrilli, Geraldine Liot, Eva Klinglmayr, Yue Zhou, Patrick Poquiz, Jonathan Tjong, Mahmoud A Pouladi, Michael R Hayden,[...]. Nat Med 2011
348
6

Insulin-like growth factor 1 (IGF-1) therapy: Mitochondrial dysfunction and diseases.
M C Sádaba, I Martín-Estal, J E Puche, I Castilla-Cortázar. Biochim Biophys Acta 2016
34
14

Akt and mTOR mediate programmed necrosis in neurons.
Q Liu, J Qiu, M Liang, J Golinski, K van Leyen, J E Jung, Z You, E H Lo, A Degterev, M J Whalen. Cell Death Dis 2014
86
6

Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats.
Juan E Puche, María García-Fernández, Jordi Muntané, José Rioja, Salvador González-Barón, Inma Castilla Cortazar. Endocrinology 2008
83
6

PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions.
Karina Sánchez-Alegría, Manuel Flores-León, Evangelina Avila-Muñoz, Nelly Rodríguez-Corona, Clorinda Arias. Int J Mol Sci 2018
38
13

Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
Shyan-Yuan Kao. Biochem Biophys Res Commun 2009
35
11

Serum insulin-like growth factor I regulates brain amyloid-beta levels.
E Carro, J L Trejo, T Gomez-Isla, D LeRoith, I Torres-Aleman. Nat Med 2002
404
5

Oxidative damage in Huntington's disease pathogenesis.
Susan E Browne, M Flint Beal. Antioxid Redox Signal 2006
216
5

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
M A Reger, G S Watson, P S Green, C W Wilkinson, L D Baker, B Cholerton, M A Fishel, S R Plymate, J C S Breitner, W DeGroodt,[...]. Neurology 2008
535
5


Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.
Eugenia Trushina, Roy B Dyer, John D Badger, Daren Ure, Lars Eide, David D Tran, Brent T Vrieze, Valerie Legendre-Guillemin, Peter S McPherson, Bhaskar S Mandavilli,[...]. Mol Cell Biol 2004
363
5

The insulin-like growth factor system and its pleiotropic functions in brain.
V C Russo, P D Gluckman, E L Feldman, G A Werther. Endocr Rev 2005
337
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.